CONBA(SH:600572) Shang Hai Zheng Quan Bao·2025-11-28 20:04Core Viewpoint - Zhejiang Conba Pharmaceutical Co., Ltd. is notifying creditors about a reduction in registered capital due to the cancellation of repurchased shares, which will decrease the registered capital from 2,570,037,319 yuan to 2,506,458,271 yuan [2][3]. Group 1: Reasons for Notifying Creditors - The company's board of directors approved the modification of the Articles of Association and the registration of changes due to the cancellation of repurchased shares during a board meeting on October 27, 2025 [2]. - A temporary shareholders' meeting was held on November 13, 2025, to further approve the amendments to the Articles of Association [2]. Group 2: Information for Creditors - Creditors have the right to declare their claims within 30 days of receiving the notification or within 45 days from the date of this announcement if they have not received any notification [3]. - The company will continue to fulfill its obligations based on the original debt documents if creditors do not exercise their rights within the specified period [3]. Group 3: Required Materials for Claim Declaration - Creditors must provide original and photocopied documents proving the existence of the debt relationship, including contracts and agreements [4]. - For corporate creditors, additional documents such as the business license and identification of the legal representative are required [4]. - Individual creditors must present valid identification and, if applicable, an authorization letter for representatives [4]. Group 4: Claim Declaration Process - The claim declaration period is set from November 29, 2025, to January 12, 2026 [5]. - Creditors can submit their claims in person or by mail, with specific contact details provided for further inquiries [6].